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Measurement of Mitochondrial Toxicity Parameters 
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Abstract
Recent discoveries have focused on mitochondria functions in the neuroscience research for approaches to 
study mitochondria dysfunction in neurodegenerative diseases. Mitochondrion is one of the organelles 
that is possibly worst affected in cognitive impairments. These are known as “powerhouse” of the cell as 
they are the main source of generation of ATP through aerobic respiration. They have role in oxidative 
phosphorylation and metabolism, they play central role in cell differentiation, apoptosis, oxygen sensing 
and detoxification of reactive oxygen species, innate immunity, mitochondrial matrix calcium, and mainte-
nance of cell quality and regulation of cytoplasmic. There is a relationship between mitochondrial dysfunc-
tion and cognitive disorder that may be related to certain neurotoxins or mutations in mitochondrial DNA 
as well as the nuclear. Evaluating compounds for mitochondrial toxicity is an important capability for 
evaluation of cognitive effects by drugs. Studying mitochondria isolated from individual mouse brain 
regions is a challenge because of small amount of the available brain tissue. There are conventional tech-
niques for isolation and purification of mitochondria from ventral midbrain, hippocampus, or striatum. 
The utilization of alcohol within pregnancy impairs the development of the unborn offspring and can lead 
to a plethora of anatomical, behavioral, and cognitive abnormalities.
In here, a method for isolation of brain mitochondria from mouse is described. The method utilizes 
a refrigerated tabletop microtube centrifuge, and produces research grade quality mitochondria in amounts 
sufficient for performing multiple enzymatic and functional assays, thereby eliminating the necessity for 
pooling mouse brain tissue. A method for measuring ROS measurement, mitochondrial membrane poten-
tial, mitochondrial swelling, cytochrome c release, and mtDNA alterations after exposure to drugs is also 
included.
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1 Introduction
Mitochondria are pleomorphic and dynamic organelles. The main 
role of mitochondria is the production of energy as adenosine tri-
phosphate, heat production by decoupling of the oxidative phos-
phorylation, translation and transcription of mitochondrial genes, 
and induction of cell death by apoptosis [1]. Mitochondria play a 
main role in apoptosis, and mitochondrial dysfunction emerges to 
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have a certain impact on the pathogenesis of neurodegenerative 
diseases. Mitochondrial dysfunction is a hallmark of many disorder 
that cause brain impairments and impinge on cognitive function, 
such as neurodegenerative diseases, aging and genetic mitochon-
drial disorders [2, 3]. Research has been directed at elucidating the 
involvement of mitochondria and defects in mitochondrial oxida-
tive phosphorylation in late-onset neurodegenerative disorders. 
Numerous studies have now uncovered divergent roles for mito-
chondria that go well beyond ATP production. The major class of 
drugs to treat affective spectrum disorders has been evidenced to 
affect mitochondrial function; for example new-generation antide-
pressive therapeutics have preferential action on mitochondrial 
metabolism [4]. The toxicity of many drugs is manifested through 
the production of reactive oxygen species (ROS) that may lead to 
mitochondrial damage. Therefore, the evaluation of mitochondrial 
health in postnatal mouse could be effective in determination of 
induced damages by new candidate drugs and other chemicals.
In this chapter a method for isolation of brain mitochondria 
that allows the isolation of a workable amount of mitochondria 
from 7 to 12 mg brain samples is described. In addition, the most 
useful and frequently assessed mitochondria functional characteris-
tics such as ROS formation, mitochondrial membrane potential, 
mitochondrial swelling, cytochrome c release, and mtDNA dam-
age are described.
2 Materials
 1. A surgical set for removing of brain.
 2. Kontes glass homogenizer, small clearance pestle.
 3. Bucket filled with ice.
 4. A refrigerated microtube centrifuge.
 5. Microcentrifuge tubes (see Note 1).
 6. Glass or plastic dissection support surface such as Petri dish 
and a piece of Whatman paper.
 7. Plate reader capable of measuring fluorescence and absorbance 
multiwavelengths.
 8. Pipettor and tips.
 9. Mannitol–sucrose–EGTA (MSEGTA) buffer: 225 mM man-
nitol, 75 mM sucrose, 5 mM HEPES (pH 7.4), 1 mM EGTA, 
dissolved in water (see Note 2). Store between 0 and 4 °C (see 
Note 3).
 10. MSEGTA–BSA: MSEGTA buffer supplemented with 0.2 mg/
mL bovine serum albumin (BSA) essentially fatty acid-free. 
Store between 0 and 4 °C.
2.1 Brain 
Mitochondria Isolation
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 11. 100% Percoll™–MSEGTA buffer: 225 mM mannitol, 75 mM 
sucrose, 5 mM HEPES (pH 7.4), 1 mM EGTA, dissolved in 
100% Percoll™. Store between 0 and 4 °C.
 12. Experimental buffer: 8 mM KCl, 110 mM potassium gluco-
nate, 10 mM NaCl, 10 mM HEPES (acid), 10 mM KH2PO4 
0.005 mM EGTA, 10 mM mannitol, 1.5 mM MgCl2, 0.5 mg/
mL BSA essentially fatty acid-free, pH 7.25 (adjusted with 
KOH). Store at 4 °C.
 13. 0.5 M EDTA.
 14. 1 M MgCl2.
 1. Bovine serum abumin (BSA) (see Note 4).
 2. Coomassie Brilliant Blue G-250.
 3. Methanol.
 4. Phosphoric acid (H3PO4).
 5. Bradford reagent.
 6. Spectrophotometer.
 7. Whatman paper.
 1. Isolated mitochondria (see Note 5).
 2. Incubation buffer: 125 mM KCl, 4 mM KH2PO4, 14 mM 
NaCl, 20 mM HEPES–NaOH, pH 7.2, 1 mM MgCl2, 0.2% of 
fatty acid-free bovine serum albumin, and 0.020 mM EGTA.
 3. 10 μM 2′,7′-dichlorodihydrofluorescein (DCF): Prepare a 
stock solution of DCF at 10 mM in dimethylsulfoxide 
(DMSO). Further dilute it to 10 μM in DMSO.
 4. H2O2 solution in water, 30–32 wt.%.
 5. Respiratory substrates (5 mM sodium succinate) and inhibitors 
(2 μM Rotenone).
 6. Small (5–10 mL) glass tubes (see Notes 7 and 8).
 7. Glass (preferable) or plastic disposable cuvettes with all walls 
transparent and flat bottom and matching stirring bars.
 8. A quartz cuvette.
 9. Fluorimeter equipped with a stirred thermostated cuvette 
holder.
 10. Common labware such as pipettors and tips.
 1. Isolated mitochondria (see Note 5).
 2. MMP assay buffer: 220 mM sucrose, 68 mM d-mannitol, 
10 mM KCl, 5 mM KH2PO4, 2 mM MgCl2, 50 μM EGTA, 
5 mM sodium succinate, 10 mM HEPES, 2 μM Rotenone.
 3. 10 μM Rhodamine 123: Prepare a stock solution at 10 mM in 
dimethylsulfoxide (DMSO). Further dilute it to 10 μM in DMSO.
2.2 Measurement 
of Mitochondrial 
Concentration
2.3 ROS Formation
2.4 Mitochondrial 
Membrane Potential 
(MMP) Collapse 
Measurement
Mitochondrial Toxicity in Embryonic Hippocampus
540
 4. Respiratory substrates (5 mM sodium succinate) and inhibitors 
(2 μM Rotenone).
 5. Small (5–10 mL) glass tubes (see Notes 7 and 8).
 6. Glass (preferable) or plastic disposable cuvettes with all walls 
transparent and flat bottom and matching stirring bars.
 7. A quartz cuvette.
 8. Fluorimeter equipped with a stirred thermostated cuvette 
holder.
 9. Common labware such as pipettors and tips.
3 Methods
 1. Anesthetize postnatal mice with an intraperitoneal injection 
(800 μL) of pentobarbital and perfused intracardially with 4% 
paraformaldehyde (PFA) in 0.1 M phosphate buffer, pH 7.4 at 
4 °C.
 2. Remove the brain from the skull and place excised brain on the 
ice-chilled glass or plastic surface (a petri dish) covered with 
wet Whatman paper; wash out the blood out of the brain sur-
face (use mitochondria isolation buffer to wash and to wet the 
paper).
 3. Using sterile scissors or scalpel, open cranium of pup from 
back of the neck to the nose. Carefully remove the entire brain 
with forceps. Place the brain on sterile gauze. Using a sterile 
scalpel, remove the cerebellum and incise down the midline of 
the brain to separate it into two hemispheres (see Fig. 1a of 
Chapter 30).
 4. Grasp a small section of meninges surrounding the hippocam-
pus with sterile forceps and pull it gently away. In either case, 
the hippocampus will be more clearly visible after the meninges 
have been removed. The hippocampus is a curved structure 
that starts in the distal part of the hemisphere and bends ven-
trally (see Fig. 1b of Chapter 30).
 5. Immediately place it in 1 mL of ice-cold MSEGTA-BSA 
buffer.
 6. Homogenize hippocampus tissue obtained in step and add 
1 mL MSEGTA-BSA with 2 mL homogenizer, tight pestle, 
with 30–35 strokes, transfer into two 1.7 mL microcentrifuge 
tubes.
 7. Add MSEGTA-BSA to the tubes up to the groove at the top 
(~1.7 mL, total volume), mix by pipetting or inversion.
 8. Centrifuge at ~500 × g × 5 min. Transfer the supernatant into 
clean 1.7 mL microcentrifuge tubes and centrifuge at 
14,000 × g × 10 min.
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 9. While centrifuging at step 7, fill 1.7 mL microcentrifuge tube 
with 1 mL of 24% Percoll MSEGTA, and prepare 12% 
Percoll™-MSEGTA, 0.2 mL (take 0.1 mL of 24% Percoll™- 
MSEGTA and dilute with 0.1 mL MSEGTA) and keep both 
24% and 12% Percoll™-MSEGTA-filled tubes in ice.
 10. Aspirate off the supernatant and resuspend both pellets (com-
bine them) in 0.2 mL of 12% Percoll™-MSEGTA.
 11. Carefully layer the suspension over the 24% Percoll™-MSEGTA 
solution, by holding the tube at about 30°, placing the tip of 
the pipettor into the tube’s groove and slowly releasing the 
suspension. Close the tube, turn it upright and place in ice 
before proceeding to the next step. Fill another 1.7 mL micro-
centrifuge tube with 1.2 mL of MSEGTA to use as a counter-
balance in the centrifuge.
 12. Centrifuge at 18,000 × g × 15 min. After the centrifugation is 
completed, check the appearance of the sample. There should 
be almost transparent band approximately in the middle of the 
tube, with cloudy top and bottom portions of the sample.
 13. Aspirate off 0.7 mL of the top portion of the sample.
 14. Add 1.2 mL MSEGTA, mix by inversion, and centrifuge at 
18,000 × g × 5 min.
 15. Aspirate 1.5 mL of the supernatant, resuspend the pellet in the 
remaining 0.2 mL of the isolation buffer, add 1.5 mL MSEGTA, 
mix by inversion and centrifuge at 14,000 × g × 5 min.
 16. If the pellet is fuzzy, repeat previous step 14.
 17. If the pellet appears solid with well-defined shape, aspirate off 
the supernatant completely and resuspend the pellet in 0.1 mL 
MSEGTA. This is purified mitochondrial fraction (see Note 3).
 1. Dissolve 50 mg of Coomassie Brilliant Blue G-250 in 50 mL 
of methanol and add 100 mL 85% (w/v) phosphoric acid 
(H3PO4).
 2. Add the acid solution mixture slowly into 850 mL of H2O and 
let the dye dissolve completely.
 3. Filter using Whatman #1 paper to remove the precipitates just 
before use. Store in a dark bottle at 4 °C.
 1. Prepare five dilutions of a protein (usually BSA) standard with 
a range of 5–100 μg protein.
 2. Dilute unknown protein samples to obtain 5–100 μg 
protein/30 μL.
 3. Add 30 μL of each standard solution or unknown protein sam-
ple to an appropriately labeled test tube.
3.1 Mitochondrial 
Concentration
3.1.1 Bradford Reagent 
Preparation
3.1.2 Measurement 
of Mitochondrial 
Concentration
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 4. Set two blank tubes. For the standard curve, add 30 μL H2O 
instead of the standard solution. For the unknown protein 
samples, add 30 μL protein preparation buffer instead. Protein 
solutions are normally assayed in duplicate or triplicate.
 5. Add 1.5 mL of Bradford reagent to each tube and mix well.
 6. Incubate at room temperature (RT) for at least 5 min. 
Absorbance will increase over time; samples should incubate at 
RT for no more than 1 h.
 7. Measure absorbance at 595 nm.
 8. Prepare five standard solutions (1 mL each) containing 0, 10, 
20, 30, 40 and 50 μg/mL BSA.
 9. Pipet 800 μL of each standard and sample solution (contain-
ing for <50 μg/mL protein) into a clean, dry test tube. Protein 
solutions are normally assayed in duplicate or triplicate.
 10. Add 200 μL of dye reagent concentrate to each tube and 
vortex.
 11. Follow the procedure described above for the standard assay 
procedure.
 1. Fill two tubes with 5 mL of deionized water.
 2. To the first tube, add 5 μL of 30% (v/v) H2O2 solution (1: 
1000 dilution), mix well.
 3. Determine the concentration of H2O2 spectrophotometrically 
by placing 2 mL of this solution in a quartz cuvette and read-
ing its absorbance at 240 nm; calculate the concentration of 
H2O2 employing the extinction coefficient ε240 = 43.6/M/
cm.
 4. Dilute H2O2 solution to ~0.1 mM by taking 50 μL of H2O2 
solution from this tube and adding it to the second tube (1:100 
dilution), mix well.
 5. Keep the second tube in ice and use within 1 h to calibrate the 
H2O2 assay.
 1. Set the fluorimeter at 488 nm excitation and 527 nm emission 
wavelengths.
 2. Turn on the cuvette holder’s thermostat set at the desired tem-
perature (25–37 °C).
 3. Fill a cuvette with the incubation buffer, add magnetic stirring 
bar, turn on the stirrer, and wait until the cuvette reaches the 
desired temperature (25–37 °C).
 4. Add 10 μM DCF and mitochondria (0.03–0.1 mg/mL) to the 
cuvette.
3.2 ROS 
Measurement
3.2.1 H2O2 Calibration 
Solution
3.2.2 Mitochondrial H2O2 
Emission
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 5. Record the fluorescence for ~150 s.
 6. The data could be presented by % of control and fluorescence 
intensity (see Note 6).
 1. Set the fluorimeter at 490 nm excitation and 535 nm emission 
wavelengths.
 2. Turn on the cuvette holder’s thermostat set at the desired tem-
perature (25–37 °C).
 3. Fill a cuvette with the incubation buffer, add magnetic stirring 
bar, turn on the stirrer, and wait until the cuvette reaches the 
desired temperature (25–37 °C).
 4. Add 10 μM Rhodamine 123 and mitochondria (0.03–0.1 mg/
mL) to the cuvette.
 5. Record the fluorescence for ~150 s.
 6. The data could be presented by % of control and fluorescence 
intensity (see Note 7).
4 Notes
 1. Eppendorf tubes can be substituted with any other brand of 
small polypropylene tubes of similar volume, with a conical 
bottom. For all aliquoted reagents, use only noncolored, clear 
plastic tubes.
 2. All water solutions and reagents are prepared using distilled 
water.
 3. The frozen stocks of the mitochondrial substrates are stable for 
at least 1 year. It is difficult to prepare K+ malate stocks at a 
concentration higher than 0.5 M.
 4. The experimental buffer contains BSA, and therefore it tends 
to foam. While pipetting materials in the well, care must be 
taken to avoid extra foaming, that may affect the fluorescence 
signal.
 5. Quality of and purity of mitochondria is very important.
 6. Contamination of mitochondrial preparation with cytosolic 
structures such as peroxisomes, synaptic terminals, etc. and 
with fragments of broken mitochondria can significantly inter-
fere with ROS and MMP collapse measurements.
 7. The other mitochondrial toxicity parameters such as mito-
chondrial swelling, cytochrome c and ATP/ADP ratio also 
could be measured in isolated mitochondria obtained hippo-
campus using appropriate protocols and ready kits.
3.3 MMP Collapse 
Measurement
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